IBDEI1AW ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20797,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,20797,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,20798,0)
 ;;=A81.9^^95^1023^71
 ;;^UTILITY(U,$J,358.3,20798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20798,1,3,0)
 ;;=3^Prion Disease
 ;;^UTILITY(U,$J,358.3,20798,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,20798,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,20799,0)
 ;;=F02.81^^95^1023^32
 ;;^UTILITY(U,$J,358.3,20799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20799,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,20799,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,20799,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,20800,0)
 ;;=F02.80^^95^1023^33
 ;;^UTILITY(U,$J,358.3,20800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20800,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,20800,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,20800,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,20801,0)
 ;;=G31.84^^95^1023^63
 ;;^UTILITY(U,$J,358.3,20801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20801,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PRION DISEASE
 ;;^UTILITY(U,$J,358.3,20801,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,20801,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,20802,0)
 ;;=S06.2X9S^^95^1023^74
 ;;^UTILITY(U,$J,358.3,20802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20802,1,3,0)
 ;;=3^TRAUMATIC BRAIN INJURY,Diffuse w/ Unspec Duration of LOC,Sequela
 ;;^UTILITY(U,$J,358.3,20802,1,4,0)
 ;;=4^S06.2X9S
 ;;^UTILITY(U,$J,358.3,20802,2)
 ;;=^5020755
 ;;^UTILITY(U,$J,358.3,20803,0)
 ;;=F02.81^^95^1023^50
 ;;^UTILITY(U,$J,358.3,20803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20803,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,20803,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,20803,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,20804,0)
 ;;=F02.80^^95^1023^51
 ;;^UTILITY(U,$J,358.3,20804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20804,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,20804,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,20804,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,20805,0)
 ;;=G31.84^^95^1023^64
 ;;^UTILITY(U,$J,358.3,20805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20805,1,3,0)
 ;;=3^Mild Neurocog D/O d/t TBI
 ;;^UTILITY(U,$J,358.3,20805,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,20805,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,20806,0)
 ;;=F01.51^^95^1023^48
 ;;^UTILITY(U,$J,358.3,20806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20806,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,20806,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,20806,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,20807,0)
 ;;=F01.50^^95^1023^49
 ;;^UTILITY(U,$J,358.3,20807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20807,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,20807,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,20807,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,20808,0)
 ;;=G31.84^^95^1023^65
 ;;^UTILITY(U,$J,358.3,20808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20808,1,3,0)
 ;;=3^Mild Neurocog D/O d/t VASCULAR DISEASE
 ;;^UTILITY(U,$J,358.3,20808,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,20808,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,20809,0)
 ;;=R41.9^^95^1023^68
 ;;^UTILITY(U,$J,358.3,20809,1,0)
 ;;=^358.31IA^4^2
